Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Jonathan
No social account linked
Launched
8mo ago
2026-03-11 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events3 marketing moves

Marketing moves

Launches, search & content, referrals, promotions
X accounts@buildwhat
  • Launched on Product HuntLaunch

    Find your next tech idea

    Mar 13 · 8mo agoLaunch page

  • Launched on Show HN (2 pts)Launch

    Buildwhat.org – Find the next tech idea — The idea came from noticing when reading tech news / comments and thinking "someone should build that". So I wanted to automate this and t…

    Mar 12 · 8mo agoLaunch page

  • Launched on Show HN (3 pts · 2 comments)Launch

    Buildwhat.org – Find tech business ideas — Every day, the top HN posts are analyzed and the most promising startup ideas are surfaced, scored, and explained in one place. Each idea…

    Mar 11 · 8mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2026-03-13

Key pages

Desktop & mobile archive
Home
buildwhat.org/ Snapshot 2026-11-07

Questions & evidence

How much website traffic does Buildwhat get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Buildwhat and what platforms does it support?
Buildwhat is catalogued under Market & Competitive Intelligence: Ideas board. Supported platforms: Web.

Related products in this category

Data & Analytics / Market & Competitive Intelligence

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.